Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Liang Zhao, Hongbin Yang, Yaochun Li, Zhongqing Wang, Li Zhou, Xielan Zhao & Jie Peng. (2022) Joint status and related risk factors in patients with severe hemophilia A: a single-center cross-sectional study. Hematology 27:1, pages 80-87.
Read now
Read now
Runhui Wu, Jing Sun, Weiqun Xu, Qun Hu, Wenqian Li, Jianwen Xiao, Feng’e Yang, Xiaojing Zeng, Yun Zeng, Jianfeng Zhou, Irina Matytsina, Sali Zhang, Michael Pluta & Renchi Yang. (2020) Safety and Efficacy of Turoctocog Alfa in the Prevention and Treatment of Bleeding Episodes in Previously Treated Patients from China with Severe Hemophilia A: Results from the Guardian 7 Trial. Therapeutics and Clinical Risk Management 16, pages 567-578.
Read now
Read now
Renchi Yang, Yongqiang Zhao, Xuefeng Wang, Jing Sun, Runhui Wu, Chenghao Jin, Jie Jin, Depei Wu, Pablo Rendo, Feifei Sun, Jeremy Rupon, Francois Huard, Joan M Korth-Bradley, Lihong Xu, Binyu Luo & Yingxue Cathy Liu. (2020) Safety and Efficacy of Moroctocog Alfa (AF-CC) in Chinese Patients with Hemophilia A: Results of Two Open-Label Studies. Journal of Blood Medicine 11, pages 439-448.
Read now
Read now
Articles from other publishers (9)
Jamil Hmida, Thomas Hilberg, Pia Ransmann, Fabian Tomschi, Claudia Klein, Sebastian Koob, Alexander Franz, Heinrich Richter, Johannes Oldenburg & Andreas C. Strauss. (2022) Most subjectively affected joints in patients with haemophilia – what has changed after 20 years in Germany?. Haemophilia 28:4, pages 663-670.
Crossref
Crossref
Carmen Escuriola Ettingshausen, Renchi Yang, Wenman Wu & Shannon L. Meeks. (2022) Inhibitors: Diagnostic challenges, unknowns of inhibitor development, treatment of bleeding and surgery, and insights into diagnosis and treatment in China. Haemophilia 28:S4, pages 111-118.
Crossref
Crossref
Jiaxin Huang, Haijia Zhu, Shuaijie Lv, Peijian Tong, Liu Xun & Shanxing Zhang. (2021) Inflammation, angiogenesis and sensory nerve sprouting in the synovium of bony ankylosed and not bony ankylosed knees with end‐stage haemophilic arthropathy. Haemophilia 27:4, pages 657-665.
Crossref
Crossref
Yongqiang Zhao, Yu Hu, Jie Jin, Xielan Zhao, Xuefeng Wang, Runhui Wu, Depei Wu, Renchi Yang, Feng’e Yang, Qun Hu, Juan Wang, Hai Fang & Werner Engl. (2021) Phase 4 Safety and Efficacy Study of Antihemophilic Factor (Recombinant) in Previously Treated Chinese Patients With Severe/Moderately Severe Hemophilia A. Clinical and Applied Thrombosis/Hemostasis 27, pages 107602962198981.
Crossref
Crossref
Xuewen Song, Jia Zhong, Feng Xue, Lingling Chen, Huiyuan Li, Donghui Yuan, Jipan Xie, Jun Shi, Lei Zhang, Eric Q. Wu & Renchi Yang. (2020) An overview of patients with haemophilia A in China: Epidemiology, disease severity and treatment strategies. Haemophilia 27:1.
Crossref
Crossref
Xueqing Dou, Man‐Chiu Poon & Renchi Yang. (2020) Haemophilia care in China: Achievements in the past decade. Haemophilia 26:5, pages 759-767.
Crossref
Crossref
Shufen Liu, Kuixing Li, Xiaoyi Zhao, Hui Cong, Qing Li & Lixia Chen. (2019) Survey of non‐physiotherapy department medical staff in China and their understanding of physiotherapy in comprehensive management of haemophilia. Haemophilia 25:3, pages 493-499.
Crossref
Crossref
Yaping Chen, Yu He, Xi Zhou, Yuan Xu, Baozhong Zhang, Yong Liu & Xisheng Weng. (2018) Application of optimized nursing process to perioperative patients with haemophilic pseudotumours. Haemophilia 24:5, pages e375-e378.
Crossref
Crossref
Hua Zhao, Peng Zhao, Yan-Ni Wang, Yu-Lin Guo & Rui-Hong Wu. (2017) Reasons for failure to continue home therapy in patients with hemophilia: A qualitative study. Chinese Nursing Research 4:4, pages 178-181.
Crossref
Crossref